iBio (IBIO) Other Non-Current Assets (2011 - 2026)
iBio's (IBIO) quarterly Other Non-Current Assets came in at $200000.0 in Q1 2026, little changed year-on-year from $200000.0 in Q1 2025, and up 1900.0% on a QoQ basis from $10000.0 in Q4 2025.
iBio (IBIO) Other Non-Current Assets (2011 - 2026) Analysis & Trends
iBio (IBIO) has 12 years of Other Non-Current Assets data on file, last reported at $200000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was $200000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $26000.0, down 87.91% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $200000.0, up from $10000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for IBIO reached as high as $6.0 million in Q3 2022 and fell as low as $10000.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $984882.4 across 5 years, with a median of $223000.0 in 2024.
- On a YoY basis, Other Non-Current Assets climbed as much as 3962.5% in 2022 and fell as far as 95.74% in 2022.
- Year by year, Other Non-Current Assets stood at $253000.0 in 2022, then soared by 413.83% to $1.3 million in 2023, then slumped by 82.85% to $223000.0 in 2024, then plunged by 95.52% to $10000.0 in 2025, then soared by 1900.0% to $200000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $200000.0 in Q1 2026, $10000.0 in Q4 2025, and $228000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 228,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 223,000.00 |
| Sep 30, 2024 | 223,000.00 |
| Jun 30, 2024 | 215,000.00 |
| Mar 31, 2024 | 215,000.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | 253,000.00 |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 29,000.00 |
| Mar 31, 2022 | 975,000.00 |
| Dec 31, 2021 | 5.94 Mn |
| Sep 30, 2021 | 1.30 Mn |
| Mar 31, 2021 | 24,000.00 |